"REVO's Senior Vice President Solomon Ali states, "Eyetalk365 is continuing in its plans to market and exploit our technology. The forecasted annual royalties to be generated from the U.S. market is in the $36 to $60 million range. Of the $36 to $60 million in total estimated annual fees projected from the marketing of the patents, Eyetalk365 LLC would receive 60% and REVO would receive 40%, or $14 to $24 million annually."